Urinary lipid changes during the development of chemically-induced renal papillary necrosis: A study using mefenamic acid and N-phenylanthranilic acid

Biomarkers

Volumn 6, Issue 6, 2001, Pages 417-427

  Thanh, N T K ^a   Stevenson, G ^a   Obatomi, D K ^a   Aicher, B ^a   Baumeister, M ^a   Bach, P H ^a  

^a UNIVERSITY OF NEW ORLEANS   (United States)

Author keywords

Early markers; Mefenamic acid; N phenylanthranilic acid; Renal papillary necrosis; Urinary phospholipids

Indexed keywords

EFENAMIC ACID; LIPID; MEFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; SPHINGOMYELIN;

ACUTE DISEASE; ANALGESIC NEPHROPATHY; ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DOSE RESPONSE; DRUG INDUCED DISEASE; HISTOPATHOLOGY; KIDNEY INJURY; KIDNEY MEDULLA; KIDNEY PAPILLA NECROSIS; LIPID STORAGE; MALE; NEPHROTOXICITY; NON INVASIVE MEASUREMENT; NONHUMAN; RAT; URINALYSIS; URINARY EXCRETION;

EID: 0035215343     PISSN: 1354750X     EISSN: None     Source Type: Journal    
DOI: 10.1080/13547500110057407     Document Type: Article

References (32)

1. The role of metabolic activation of analgesics and nonsteroidal anti-inflammatory drugs in the development of renal papillary necrosis and upper urothelial carcinoma
2. Chemically induced renal papillary necrosis and upper urothelial carcinoma
3. Renal and urinary lipid changes associated with an acutely induced renal papillary necrosis
4. Quantitative and qualitative analyses of isolated lipid droplets from interstitial cells in renal papillae from various species
5. Ultrasound diagnosis of early renal papillary necrosis
6. Analgesic nephropathy
7. Current status of chronic analgesic and nonsteroidal anti-inflammatory drug nephropathy
8. Effect of 16,16-dimethyl PGE2 on renal papillary necrosis and gastrointestinal ulcerations (gastric, duodenal, intestinal) produced in rats by mefenamic-acid
9. A long-term prospective controlled study of analgesic abuse in Belgium
10. Diagnostic criteria of analgesic nephropathy in patients with end-stage renal failure: Results of the Belgian study
11. Short- and long-term treatment with indomethacin causes renal phospholipid alteration: A possible explanation for indomethacin nephrotoxicity
12. Renal papillary necrosis - A sixteen-year clinical experience
13. N-Phenylanthranilic acid: An agent for inducing and studying renal papillary necrosis in the rat
14. The effects of N-phenylanthranilic acid-induced renal papillary necrosis on urinary acidification and renal electrolyte handling
15. Caffeine potentiation of mefenamic acid-induced lesions in the rat renal medulla
16. A standard nomenclature for structures of the kidney
17. New ideas on the anatomy of the kidney
18. Analgesic nephropathy in the 1990s. An Australian perspective
19. Regular analgesic intake and the risk of end-stage renal failure
20. Analgesic use and chronic renal-disease in patients with headache
21. Analgesic use and chronic renal disease
22. Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease
23. Progression of renal failure in analgesic-associated nephropathy
24. Analgesic nephropathy associated with paracetamol
25. Mefenamic acid nephropathy
26. Chronic nephrotoxicity of anti-inflammatory drugs used in the treatment of arthritis
27. Urinary enzymes and protein patterns as indicators of injury to different regions of the kidney
28. Phospholipiduria in 2-bromoethanamine-induced renal papillary necrosis
29. Increased urinary uronic acid excretion in experimentally-induced renal papillary necrosis in rats
30. Determination of lipids in animal tissues by high performance thin layer chromatography with densitometry
31. Etiology of acute renal failure
32. Lipid composition of the Golgi apparatus of rat kidney and liver in comparison with other subcellular organelles